Latest news

PUBLICATION

11th July 2023

Turin

PUBLISHED A NEW PAPER ON A EASY-TO-USE FORMULATION WITH ORAL CAPSULES WITH PLANT EVs FOR mRNA VACCINE DELIVERY

EvoBiotech published its last results on the use of extracellular vesicles derived from plants as a drug delivery system in the special issue “Extracellular Vesicles and Nucleic Acids in Health and Disease” of Cells Journal. This work demonstrates the use of edible plant-derived extracellular vesicles to vehicle mRNA-based vaccines for SARS-CoV-2 using an easy-to-use formulation […]

PRESS

2nd June 2023

Italy

WHO’S TALKING ABOUT US: EUStartup.news

EU Startup.news is a popular website covering news about the European startup landscape and pointing-out the most promising startups for investment opportunities. We are pleased to share that EvoBiotech has been cited as one of the 15 innovative Italian Startups that are revolutionizing biotechnology in Italy. According to EU Startup.news, EvoBiotech is a cutting-edge biotech […]

CONGRESSES

24th May 2023

Seattle (WA)

EVOBIOTECH WAS SELECTED TO PRESENT ITS RESEARCH AT ISEV 2023 CONGRESS

EvoBiotech participated to the Annual Meeting of International Society for Extracellular Vesicles (International ISEV 2023) in Seattle to present its last results on the innovative use of plant extracellular vesicles as a delivery platform for mRNA-based vaccines.